NCT04636424 is a NA clinical trial of assesment of gait in Gait, Spastic, sponsored by Cairo University.

Who is sponsoring NCT04636424?

NCT04636424 is sponsored by Cairo University.

What drugs are being tested in NCT04636424?

Interventions in NCT04636424: assesment of gait.

What condition does NCT04636424 study?

NCT04636424 studies Gait, Spastic.

Is NCT04636424 still recruiting?

NCT04636424 is currently completed. Last updated 19 November 2020.

Last reviewed 2020-11-19 · How we verify

NCT04636424

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Weight Distribution Asymmetry in Relation to Speed During Gait in Children With Spastic Cerebral Palsy.

Completed NA Last updated 19 November 2020

What this trial tests

NA trial testing assesment of gait in Gait, Spastic in 114 participants. Completed in 1 November 2020.

Timeline

3 December 2019

Primary endpoint
5 March 2020

1 November 2020

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	114
Start date	3 December 2019
Primary completion	5 March 2020
Estimated completion	1 November 2020
Sites	1 location across Egypt

Drugs / interventions tested

assesment of gait

Conditions studied

Gait, Spastic — all drugs for Gait, Spastic →

Sponsor

Cairo University

Who can join

Adults 10 to 12, any sex, with Gait, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Improving walking ability is one of the major concerns in therapeutic interventions for children with cerebral palsy. Aim: determine the relation between the weight distributed on both lower limb and speed during walking.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Weight distribution asymmetry in relation to walking speed in children with spastic cerebral palsy.
Ibrahim NM, Abbass ME. · · 2022 · cited 1× · PMID 36407341 · DOI 10.4314/ahs.v22i2.65

Verify or expand the search:

Other recruiting trials for Gait, Spastic

Currently open trials in the same condition.

NCT06543758 — Effectiveness and Safety of At-home Gait Rehabilitation Using Wearable Exoskeletal Robot · Phase 4 · recruiting
NCT04947865 — Reflex Excitability in Post-stroke Stiff-Knee Gait · NA · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04636424 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 19 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04636424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing